Lanxess Ag · XETR:LXS
Lanxess — Lanxess Ag Ord — Q1 2026 Earnings Presentation
26 slides from Lanxess's earnings presentation, May 7, 2026
Slide 1: LANXESS – Q1 2026 results
LANXESS – Q1 2026 results May 7, 2026 Matthias Zachert, CEO I Oliver Stratmann, CFO
Slide 2: Safe harbor statement
Safe harbor statement The information included in this presentation is being provided for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to purchase, securities of LANXESS AG. No public market exists for the securities of LANXESS AG in the United
Slide 3: Agenda
Agenda 1. Review Q1 2026 and outlook 2. Financial and business details Q1 2026 3. Appendix 3
Slide 4: Weak start of the year but focus on cashflow remains
Weak start of the year but focus on cashflow remains [in € m] Q1 EBITDA pre Q1 Free cash flow Net working capital Net financial debt 1,500 133 1,343 2,023 2,085 94 -29 -111 Q1 2025 Q1 2026 Q1 2025 Q1 2026 Q1 2025 Q1 2026 Q4 2025 Q1 2026 Main drivers: Improved Improved Minimal increase ▪ Lower volume
Slide 5: Middle East conflict quickly changed market conditions asking for swift and agile business reactions
Middle East conflict quickly changed market conditions asking for swift and agile business reactions Competitive landscape, supply chain & price environment led to several effects and actions Less competitive Secured supply Quick reaction Seasonal pressure from Asia chains based on through inventory
Slide 6: Iran conflict: Immanent risks and chances hard to predict
Iran conflict: Immanent risks and chances hard to predict LANXESS assumption on (short-term) segment impact is heterogeneous Consumer Protection Specialty Additives Advanced Intermediates Lower upside Moderate upside Moderate to high potential potential upside potential 6
Slide 7: FY 2026 guidance confirmed: EBITDA pre expected in €450 – 550 m range
FY 2026 guidance confirmed: EBITDA pre expected in €450 – 550 m range Our view on economic LANXESS environment outlook ▪ Significant macro-economic ▪ Considerations for FY: uncertainties persist, intensified by − Continued cost streamlining to mitigate Middle East conflict inflation, savings back-en
Slide 8: Agenda
Agenda 1. Review Q1 2026 and outlook 2. Financial and business details Q1 2026 3. Appendix 8
Slide 9: LANXESS Group: Weak start of the year gained momentum in March
LANXESS Group: Weak start of the year gained momentum in March [€ m] Q1/2025 Q1/2026 Δ o Visible increase in orders on hand in March in most businesses coming from exceptionally low levels in first Sales 1,601 1,378 -14% two months EBITDA pre 133 94 -29% o Mixed picture on volume development: Additi
Slide 10: Consumer Protection: Q1 still challenged; prior-year quarter supported by one-time effect
Consumer Protection: Q1 still challenged; prior-year quarter supported by one-time effect [€ m] Q1/2025 Q1/2026 Δ − Lower prices due to pass-through of input cost deflation and ongoing price pressure particularly in agro; effects Sales 513 458 -11% from price increases and anti-dumping measures to c
Slide 11: Specialty Additives: Positive volumes but negative FX effect held back earnings development
Specialty Additives: Positive volumes but negative FX effect held back earnings development [€ m] Q1/2025 Q1/2026 Δ − Slightly lower prices in line with pass-through of lower raw material costs for all businesses Sales 545 521 -4% + Increased volumes mainly in lubricants and brominated EBITDA pre 52
Slide 12: Advanced Intermediates: Weak quarter as expected
Advanced Intermediates: Weak quarter as expected [€ m] Q1/2025 Q1/2026 Δ − Lower prices due to pass-through of lower input costs and competitive pressure from Asia Sales 476 396 -17% + Positive effects from recent price increases expected to EBITDA pre 40 27 -33% materialize especially in BU AII in
Slide 13: P&L Q1: Decreased earnings mainly due to unfavorable FX-development and absence of Urethane Business
P&L Q1: Decreased earnings mainly due to unfavorable FX-development and absence of Urethane Business P&L [€ m] Q1/2025 Q1/2026 yoy ▪ Lower sales mainly due to Sales 1,601 1,378 -14% unfavorable FX and portfolio effect (Urethanes business) Cost of sales -1,279 -1,116 13% ▪ Lower selling expenses main
Slide 14: Cashflow statement reflects disciplined NWC management despite seasonal build-up in uncertain times
Cashflow statement reflects disciplined NWC management despite seasonal build-up in uncertain times Cash flow [€ m] Q1/2025 Q1/2026 ▪ Lower profit before tax due to lower at-equity and operating result Profit before tax -61 -136 ▪ At-equity result reflects mainly Depreciation & amortization 135 121
Slide 15: Continued strong equity ratio
Continued strong equity ratio Balance sheet [€ m] 31.12.2025 31.03.2026 ▪ Total assets and equity stable: Positive FX effects compensated Total assets 7,748 7,750 ▪ Decrease in income reduced net total assets Equity 3,500 3,498 due to €500 m bond ▪repayment, FX effect Equity ratio remains and strong
Slide 16: Q1 2026: FX & portfolio driven lower sales in weak demand environment
Q1 2026: FX & portfolio driven lower sales in weak demand environment Sales [€ m] Sales share [€ m] EBITDA pre [€ m] -14% Consumer SGO LPT -29% Protection 1,601* 133 MPP F&F 1,378* 513 94 -11% CP CP 458 Specialty LAB 73 Additives PLA 310 -15% 62 545 -4% RCH SA 521 SA 52 -15% 44 Advanced IPG AI 476 3
Slide 17: Q1 2026: Mainly volume-driven sales decline
Q1 2026: Mainly volume-driven sales decline Q1 2026 sales by region [%] Regional development of sales [€ m] Americas 1,601 Asia / Pacific Asia/Pacific 33% 291 1,378 19% -9% 266 Americas 555 -18% 457 EMEA 471 -15% 400 19% (excl. Germany) 29% Germany Germany 284 -10% 255 EMEA Q1 2025 Q1 2026 (excl. Ge
Slide 18: Targeting further €150 m structural savings by the end of 2028
Targeting further €150 m structural savings by the end of 2028 Actively adjusting our cost structure FORWARD! More to come… …implementation by: [in € m] 2026 2027 2028 Savings ~65 ~55 ~30 ▪ Reduction of ~550 positions worldwide Cash Outs1 ~25 ~15 ~10 across all functions ▪ Fluctuation & FTEs2 ~550 d
Slide 19: Lower exceptional items (on EBIT), mainly related to IT-projects
Lower exceptional items (on EBIT), mainly related to IT-projects [€ m] Q1 2025 Q1 2026 thereof thereof Excep. Excep. D&A D&A Strategic realignment and restructuring -1 0 -4 -1 (incl. FORWARD!) Strategic IT-projects -8 0 -6 -0 M&A, digitalization and -12 0 -4 -0 others Total -21 0 -14 -1 19
Slide 20: Price increases in Q1
Price increases in Q1 to actively counter-steer increasing raw material and energy costs across all segments Product / Portfolio Business Unit (Segment) Price increase Announcement Lewatit® ion Liquid Purification Technologies +6% to +8% 2026-04-07 exchange resins (CP) Sulfur-based Advanced Industri
Slide 21: Agenda
Agenda 1. Review Q1 2026 and outlook 2. Financial and business details Q1 2026 3. Appendix 21
Slide 22: Housekeeping items 2026
Housekeeping items 2026 Outlook FY 2026 (in € m) Capex ~330 Operational depreciation ~340 ▪ excluding ~€130 m of intangible amortization All other segments (EBITDA pre) -140 to -150 Exceptional expenses ~40 to 60 ▪ on EBIT, based on current projects ▪ EBITDA pre impact after hedging per cent FX sens
Slide 23: Maturity profile well balanced
Maturity profile well balanced Actively managed – ample liquidity available (as of March 2026) Long-term financing All group financing executed without financial covenants secured Bond 2026 Bond 2027 Bond 2028 Bond 2029 2030 2030+ €500 m €500 m €600 m €600 m 800 1.00% 0.00% 1.75% 0.625% Ø interest ▪
Slide 24: Contact details Investor Relations
Contact details Investor Relations Visit the IR website Eva Husmann (Frerker) Sophie Brandt Catharina Kaiser Thomas Kaiser Jens Ussler Head of Investor Relations ESG Investors and Ratings Institutional Investors / Analysts Institutional Investors / Analysts Institutional Investors / Analysts Mob.: +
Slide 25: Abbreviations
Abbreviations § Consumer Protection Specialty Additives Advanced Intermediates MPP Material Protection Products PLA Polymer Additives AII Advanced Industrial Intermediates F&F Flavors & Fragrances LAB Lubricant Additives Business IPG Inorganic Pigments SGO Saltigo RCH Rhein Chemie LPT Liquid Purific
Slide 26: Upcoming events 2026 – Proactive capital market communication
Upcoming events 2026 – Proactive capital market communication 13 UBS Pan European Small and Mid- 11 Kempen Chemicals Conference 7 Q2 Reporting Cap Conference London Frankfurt 19 Citi European Conference London 21 Annual General Meeting 26/27 dbAccess European Champions Conference Frankfurt May June